Your browser doesn't support javascript.
loading
Secukinumab shows high and sustained efficacy in nail psoriasis: 2.5-year results from the randomized placebo-controlled TRANSFIGURE study.
Reich, K; Sullivan, J; Arenberger, P; Jazayeri, S; Mrowietz, U; Augustin, M; Elewski, B; You, R; Regnault, P; Frueh, J A.
Afiliación
  • Reich K; Translational Research in Inflammatory Skin Diseases, Institute for Health Services Research in Dermatology and Nursing, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Sullivan J; Skinflammation® Center, Hamburg, Germany.
  • Arenberger P; Sutherland Hospital, University of New South Wales, Sydney, NSW, Australia.
  • Jazayeri S; Department of Dermatovenereology, Third Faculty of Medicine, Charles University, Prague, Czech Republic.
  • Mrowietz U; Alliance Dermatology and Mohs Center, Phoenix, AZ, USA.
  • Augustin M; Psoriasis Center at the Department of Dermatology, University Medical Center Schleswig-Holstein, Kiel, Germany.
  • Elewski B; Universität Hamburg, Hamburg, Germany.
  • You R; Department of Dermatology, University of Alabama, Birmingham, AL, USA.
  • Regnault P; China Novartis Institutes for BioMedical Research, Shanghai, China.
  • Frueh JA; Novartis Pharma AG, Basel, Switzerland.
Br J Dermatol ; 184(3): 425-436, 2021 03.
Article en En | MEDLINE | ID: mdl-32479641

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Psoriasis / Calidad de Vida Tipo de estudio: Clinical_trials Aspecto: Patient_preference Límite: Humans Idioma: En Revista: Br J Dermatol Año: 2021 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Psoriasis / Calidad de Vida Tipo de estudio: Clinical_trials Aspecto: Patient_preference Límite: Humans Idioma: En Revista: Br J Dermatol Año: 2021 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Reino Unido